New Oak Capital has appointed Donald McGuire as Chief Operating Officer and head of investment banking.

McGuire will play a key role in the governance of the firm. As COO, he will direct day-to-day internal operations. As head of investment banking, he will lead NewOak’s banking professionals in the company’s mission to deliver best-in-class financial services.

McGuire joins New Oak with over 27 years of unique experience in finance and operations at major investment banking, pharmaceutical, and technology companies around the globe.

Most recently, he was managing partner of KDM Advisors in Greenwich CT, working with founders, shareholders, Boards, and management teams to develop or restructure their companies. Previous to that, he served as Chairman and CEO of Metastatin Pharmaceuticals Inc., providing the leadership, strategy, and management necessary to lead a preclinical biopharmaceutical company from early stage through sale to a public company.   

Before that, McGuire was President, COO and Director of in New York and London where he led global operations and strategy as well as managing director and COO, Investment Banking-Americas for ING Barings/Furman Selz in New York.

“With the continued expansion of New Oak’s efforts in financial advisory and solutions, it is imperative to continue strengthening New Oak’s own governance and operational systems and processes for scalability," said said  Ron D’Vari, CEO and Co-Founder of New Oak in a press release today. "Executing on our client’s complex solutions in investment banking, credit services and financial disputes requires a highly experienced and disciplined team. Don has the right combination of infrastructure and team building track record to help lead such an effort.” 

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.